APA (7th ed.) Citation

S, D. B., D, L. T., A, N., M, R., N, P., R, B., . . . A, C. (2024). Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients. Nature communications, 15(1), 2752. https://doi.org/10.1038/s41467-024-47013-0

Chicago Style (17th ed.) Citation

S, De Biasi, et al. "Immunosenescence and Vaccine Efficacy Revealed by Immunometabolic Analysis of SARS-CoV-2-specific Cells in Multiple Sclerosis Patients." Nature Communications 15, no. 1 (2024): 2752. https://doi.org/10.1038/s41467-024-47013-0.

MLA (9th ed.) Citation

S, De Biasi, et al. "Immunosenescence and Vaccine Efficacy Revealed by Immunometabolic Analysis of SARS-CoV-2-specific Cells in Multiple Sclerosis Patients." Nature Communications, vol. 15, no. 1, 2024, p. 2752, https://doi.org/10.1038/s41467-024-47013-0.